Understanding the long-term outlook of paroxysmal kinesigenic choreoathetosis in Koreans
Official title: Prognosis of Paroxysmal Kinesigenic Choreoathetosis in Korea: a Prospective, Observational Study
Run by Seoul National University Hospital · NCT04023656 · Data updated 2026-11-12
This study looks at how paroxysmal kinesigenic choreoathetosis affects people in Korea over the long term to help understand their experiences and health outcomes better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | November 11, 2016 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 17, 2019 |
| Trial ID | NCT04023656 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are males and females aged 18 and older diagnosed with paroxysmal kinesigenic choreoathetosis.
✕Probably not a fit
Patients with secondary PKC caused by other disorders or those with significant neurological deficits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the long-term prognosis of paroxysmal kinesigenic choreoathetosis (PKC) specifically within the Korean population. PKC is a movement disorder characterized by involuntary movements triggered by sudden motion, and while its prognosis is generally favorable, there is limited research on its long-term outcomes in this demographic. The study will involve male and female patients aged 18 and older who have been diagnosed with PKC, focusing on their experiences and health outcomes over time. The findings could provide valuable insights into the management and treatment of PKC in Korea.
Why it matters
Potential benefit: If successful, this study could enhance understanding of PKC prognosis, leading to improved management strategies for patients.
How similar studies have gone: While there has been limited research on PKC prognosis in other populations, this study is novel in its focus on the Korean demographic.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female PKC patients who were18 years of age and older * Subjects were diagnosed as paroxysmal kinesigenic choreoathetosis (PKC) * Subjects were enrolled voluntarily and understood the contents of this trial Exclusion Criteria: * Existence of lesions on the brain * Existence of neurological deficit that suspected lesions on the brain * Existence of epileptiform discharges on electroencephalogram * Subjects with secondary PKC which was caused by other disorder or illness * Existence of illness or problems which made difficult to be enrolled to this trial judged by clinicians
Where it's running
-
Seoul National University Hospital
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: Han-joon Kim, MD, Ph.D — Seoul National University Hospital
- Study coordinator: Han-joon Kim, MD, Ph.D
- Email: movement@snu.ac.kr
- Phone: +82-2-2072-1219
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.